US Patent Issued to Akeso Biopharma on Aug. 11 for "Anti-CD47 monoclonal antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,743, issued on Aug. 11, was assigned to Akeso Biopharma Inc. (Zhongshan, China).

"Anti-CD47 monoclonal antibody and use thereof" was invented by Peng Zhang (Zhongshan, China), Baiyong Li (Zhongshan, China), Yu Xia (Zhongshan, China) and Zhongmin Wang (Zhongshan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an anti-CD47 monoclonal antibody and a use thereof, secreted by the hybridoma cell line with the deposit number CCTCC NO: C2018135."

The patent was filed on Sept. 3, 2020, under Application No. 17/640,005.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?S...